Literature DB >> 25672348

Clostridium difficile PCR Ribotype 027 Emerges in Taiwan.

Tsai-Ling Liao1, Chin-Fu Lin, Chien-Shun Chiou, Gwan-Han Shen, John Wang.   

Abstract

Clostridium difficile PCR ribotype 027 is a hypervirulent strain that has caused significant nosocomial diarrhea in many countries but has not yet been reported or isolated in Taiwan previously. Here, we present the characteristics of a case of C. difficile PCR ribotype 027 identified in Taiwan. Taiwan is located in a key transportation center of Asia. This report is important for alerting hospitals and public health departments in Asia about the emergence of this hypervirulent strain so that close monitoring may be enacted to prevent potential outbreaks.

Entities:  

Mesh:

Year:  2014        PMID: 25672348     DOI: 10.7883/yoken.JJID.2014.271

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  4 in total

Review 1.  Clostridium difficile Infection.

Authors:  Jae Hyun Shin; Esteban Chaves-Olarte; Cirle A Warren
Journal:  Microbiol Spectr       Date:  2016-06

2.  The First Two Clostridium difficile Ribotype 027/ST1 Isolates Identified in Beijing, China-an Emerging Problem or a Neglected Threat?

Authors:  Jing-Wei Cheng; Meng Xiao; Timothy Kudinha; Zhi-Peng Xu; Xin Hou; Lin-Ying Sun; Li Zhang; Xin Fan; Fanrong Kong; Ying-Chun Xu
Journal:  Sci Rep       Date:  2016-01-07       Impact factor: 4.379

3.  Comparative genomic analysis of Clostridium difficile ribotype 027 strains including the newly sequenced strain NCKUH-21 isolated from a patient in Taiwan.

Authors:  Haruo Suzuki; Masaru Tomita; Pei-Jane Tsai; Wen-Chien Ko; Yuan-Pin Hung; I-Hsiu Huang; Jenn-Wei Chen
Journal:  Gut Pathog       Date:  2017-11-29       Impact factor: 4.181

4.  Nationwide surveillance of ribotypes and antimicrobial susceptibilities of toxigenic Clostridium difficile isolates with an emphasis on reduced doxycycline and tigecycline susceptibilities among ribotype 078 lineage isolates in Taiwan.

Authors:  Yuan-Pin Hung; Pei-Jane Tsai; Yuan-Ti Lee; Hung-Jen Tang; Hsiao-Ju Lin; Hsiu-Chuan Liu; Jen-Chieh Lee; Bo-Yang Tsai; Po-Ren Hsueh; Wen-Chien Ko
Journal:  Infect Drug Resist       Date:  2018-08-15       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.